Durso Timothy August
SEC insider (Form 3/4/5 filer). CIK 0002107508. Chief Technical Officer at Veradermics, Inc (MANE). 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in NEW HAVEN, CT.
Companies Durso Timothy August has filed insider reports for
- Veradermics, Inc (MANE): Officer, Chief Technical Officer
Durso Timothy August
CIK: 0002107508
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)5 (62.5%)
Position reduction
Option Exercises (M)1 (12.5%)
Derivative conversions
Awards (A)1 (12.5%)
Compensation grants
Other (G, F, J, C, D, …)1 (12.5%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MANE
Veradermics, Inc
Officer
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 17, 2026MANE
Veradermics, Inc
ExerciseDirect3.5K shares at avg. $12.19$42K - Aug 17, 2026MANE
Veradermics, Inc
SaleDirect7.9K shares at avg. $106.71$845K - Aug 17, 2026MANE
Veradermics, Inc
SaleDirect16.3K shares at avg. $107.52$1.8M - Aug 17, 2026MANE
Veradermics, Inc
SaleDirect16.8K shares at avg. $108.38$1.8M - Aug 17, 2026MANE
Veradermics, Inc
SaleDirect2.3K shares at avg. $109.34$257K - Aug 17, 2026MANE
Veradermics, Inc
SaleDirect161 shares at avg. $111.28$18K - Feb 5, 2026MANE
Veradermics, Inc
ConversionDirect1.5K shares- - Feb 3, 2026MANE
Veradermics, Inc
AwardDirectStock Option (Right to Buy)
213.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 | MANE Veradermics, Inc | Exercise | 3,452 | $12.19 | $42,080 | Direct |
| Aug 17, 2026 | MANE Veradermics, Inc | Sale | 7,918 | $106.71 | $844,930 | Direct |
| Aug 17, 2026 | MANE Veradermics, Inc | Sale | 16,306 | $107.52 | $1,753,221 | Direct |
| Aug 17, 2026 | MANE Veradermics, Inc | Sale | 16,767 | $108.38 | $1,817,207 | Direct |
| Aug 17, 2026 | MANE Veradermics, Inc | Sale | 2,348 | $109.34 | $256,730 | Direct |
| Aug 17, 2026 | MANE Veradermics, Inc | Sale | 161 | $111.28 | $17,916 | Direct |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 1,473 | - | $0 | Direct |
| Feb 3, 2026 | MANE Veradermics, Inc | Award Stock Option (Right to Buy) | 213,352 | - | - | Direct |
1-8 of 8 transactions